Pfizer Inc. (PFE) Total liabilities 2016–2025
Pfizer Inc. (PFE) total liabilities at each fiscal year-end, per SEC filings.
$121.4BFY2025 · since FY2016: $111.8B → $121.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $121.4B | -2.8% |
| FY2024 | $124.9B | -9.0% |
| FY2023 | $137.2B | +35.5% |
| FY2022 | $101.3B | -2.6% |
| FY2021 | $104.0B | +14.6% |
| FY2020 | $90.8B | -12.9% |
| FY2019 | $104.1B | +8.9% |
| FY2018 | $95.7B | -4.5% |
| FY2017 | $100.1B | -10.4% |
| FY2016 | $111.8B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice